SCHEMBL10563531

SCHEMBL10563531

COc1ccc2c(=O)c(-c3cccc(C(=O)O)c3)coc2c1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.48
▸ ALDH1A1 P00352 5/20 0.48
▸ TP53 P04637 3/20 0.48
▸ CYP3A4 P08684 3/20 0.48
▸ MEN1 O00255 3/20 0.48
▸ KMT2A Q03164 3/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ LMNA P02545 1/20 0.48
▸ THRB P10828 1/20 0.48
▸ ALOX15 P16050 3/20 0.46
▸ ALOX12 P18054 3/20 0.46
▸ PIK3CA P42336 1/20 0.46
▸ KDM4E B2RXH2 4/20 0.45
▸ NPC1 O15118 4/20 0.45
▸ RAB9A P51151 4/20 0.45
▸ MAPK1 P28482 2/20 0.45
▸ HSD17B10 Q99714 2/20 0.45
▸ PPARG P37231 2/20 0.44
▸ PPARD Q03181 1/20 0.44
▸ PPARA Q07869 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10655527 0.86 ALDH1A1 (0.47) MAPTALDH1A1TP53CYP3A4MEN1
SCHEMBL4680788 0.84 ALDH1A1 (0.57) MAPTALDH1A1TP53CYP3A4MEN1
SCHEMBL28730377 0.81 MAPT (0.63) MAPTALDH1A1TP53CYP3A4MEN1
SCHEMBL29550916 0.81 MAPT (0.63) MAPTALDH1A1TP53CYP3A4MEN1
SCHEMBL571684 0.80 MAPT (0.54) MAPTALDH1A1TP53CYP3A4MEN1
SCHEMBL10562125 0.78 ALOX15 (0.71) MAPTALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL10655498 0.77 ALDH1A1 (0.65) MAPTALDH1A1TP53CYP3A4MEN1
SCHEMBL32667382 0.77 ACHE (0.46) MAPTALDH1A1TP53CYP3A4MEN1
SCHEMBL1616095 0.77 STIM1 (0.54) LMNARAB9AMAPK1STIM1ORAI1
SCHEMBL10564727 0.76 MAPT (0.60) MAPTALDH1A1TP53CYP3A4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4814346-A Benzopyrans and use thereof in treating vascular diseases ZYMA SA (CH) 1989-03-21 — — US disclosed
EP-0267155-A2 Bicyclic compounds Zyma SA (CH) 1988-05-11 — — EP disclosed
Send feedback